Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru

International Journal of Cancer

Volumn 121, Issue 4, 2007, Pages 796-802

  Almonte, Maribel ^a,b   Ferreccio, Catterina ^c   Winkler, Jennifer L ^d   Cuzick, Jack ^a   Tsu, Vivien ^d   Robles, Sylvia ^e,f   Takahashi, Rina ^g   Sasieni, Peter ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d PATH   (United States)

^e PAN AMERICAN HEALTH ORGANIZATION   (United States)

^f WORLD BANK   (United States)

^g INSTITUTO NACIONAL DE ENFERMEDADES NEOPLÁSICAS   (Peru)

Author keywords

Clinical trial; Hybrid capture; Low resource settings; Pap smear; Screening

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CARCINOMA IN SITU; CLINICAL EXAMINATION; COLPOSCOPY; CONTROLLED STUDY; CRYOTHERAPY; DEVELOPING COUNTRY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PERU; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS DIAGNOSIS; WART VIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; FEMALE; HUMANS; MIDDLE AGED; PERU; PHYSICAL EXAMINATION; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 34547127374     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22757     Document Type: Article

References (37)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37:S4-S66.
2. IARC Working Group on Cervical Cancer Screening, The UICC Project Group on the Evaluation of Screening Programmes for Cancer. Screening for cancer of the uterine cervix. Lyon: IARC Scientific Publications, 1986.1-315.
3. Hakama M, Louhivuori K. A screening programme for cervical cancer that worked. Cancer Surv 1988;7:403-16.
4. Sasieni PD, Cuzick J, Lynch-Farmery E. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer 1996;73:1001-5.
5. Gage JC, Ferreccio C, Gonzales M, Arroyo R, Huivin M, Robles SC. Follow-up care of women with an abnormal cytology in a low-resource setting. Cancer Detect Prev 2003;27:466-71.
6. Lazcano-Ponce EC, Moss S, Alonso de Ruiz P, Salmeron Castro J, Hernandez Avila M. Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico. Arch Med Res 1999;30:240-50.
7. IARC. IARC handbooks of cancer prevention, vol. 10: Cervix cancer screening. Lyon: IARC Press, 2005.
8. Sankaranarayanana B, Syamalakumari R, Wesley R, Somanathan T, Chandralekha B, Sreedevi Amma N, Parkin DM. Visual inspection as a screening test for cervical cancer control in developing countries. In: Franco E, Monsonego J, eds. New developments in cervical cancer screening and prevention, 1st ed. Oxford: Blackwell Science, 1997.411-21.
9. Belinson JL, Pretorius RG, Zhang WH, Wu LY, Qiao YL, Elson P. Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol 2001;98:441-4.
10. University of Zimbabwe, JHPIEGO Cervical Cancer Project. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. Lancet 1999;353:869-73.
11. Singh V, Sehgal A, Parashari A, Sodhani P, Satyanarayana L. Early detection of cervical cancer through acetic acid application - an aided visual inspection. Singapore Med J 2001;42:351-4.
12. Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CC, Sharma R, Dolo A, Shastri SS, Nacoulma M, Nayama M, Somanathan T, et al. Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa. Int J Cancer 2004;110:907-13.
13. Instituto Nacional de Estadistica e Informatica (INEI). Perú en Mapas: Atlas en base al Censo de Población y Vivienda. IX Censo Nacional de Población y IV de Vivienda 1993. Instituto Nacional de Estadística e Informática (INEI), Lima 1997.
14. Sarian LO, Derchain SF, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo R, Braganca JF, et al. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. J Med Screen 2005; 12:142-9. This report refers to partial results from the LAMS (Latin American Screening) study.
15. Cecchini S, Bonardi R, Mazzotta A, Grazzini G, Iossa A, Ciatto S. Testing cervicography and cervicoscopy as screening tests for cervical cancer. Tumori 1993;79:22-5.
16. Chirenje ZM, Chipato T, Kasule J, Rusakaniko S. Visual inspection of the cervix as a primary means of cervical cancer screening: results of a pilot study. Central Afr J Med 1999;45:30-3. Erratum 1999;45:79.
17. Belinson J, Qiao YL, Pretorius R, Zhang WH, Elson P, Li L, Pan QJ, Fischer C, Lorincz A, Zahniser D. Shanxi province cervical cancer screening study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001;83:439-44.
18. Denny L, Kuhn L, Pollack A, Wright TC, Jr. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer 2002;94:1699-707.
19. Herbert A, Johnson J. Personal view. Is it reality or an illusion that liquid-based cytology is better than conventional cervical smears? Cytopathology 2001;12:383-4.
20. Cuzick J, Sasieni P, Davies P, Adams J, Normand C, Frater A, van Ballegooijen M, van den Akker-van Marle E. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions. Br J Cancer 2000; 83:561-5.
21. Cuzick J. Role of HPV testing in clinical practice. Virus Res 2002;89:263-9.
22. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006;119:1095-101.
23. Ferreccio C, Bratti MC, Sherman ME, Herrero R, Wacholder S, Hildesheim A, Burk RD, Hutchinson M, Alfaro M, Greenberg MD, Morales J, Rodriguez AC, et al. A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer. Cancer Epidemiol Biomarkers Prev 2003;12:815-23.
24. Santos C, Munoz N, Klug S, Almonte M, Guerrero I, Alvarez M, Velarde C, Galdos O, Castillo M, Walboomers J, Meijer C, Caceres E. HPV types and cofactors causing cervical cancer in Peru. Br J Cancer 2001;85:966-71.
25. Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ, Vaccarella SV, Jara AT, Puschel KI, Robles SC, Herrero R, Franceschi SF, et al. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 2004;13:2271-6.
26. Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S, Meijer CJ, Arslan A, Munoz N. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002;87:324-33.
27. Levi JE, Fink MC, Canto CL, Carretiero N, Matsubara R, Linhares I, Das Dores GB, Castelo A, Segurado A, Uip DE, Eluf JJ. Human papillomavirus prevalence, viral load and cervical intraepithelial neoplasia in HIV-infected women. Braz J Infect Dis 2002;6:129-35.
28. Oliveira ER, Derchain SF, Rabelo-Santos SH, Westin MC, Zeferino LC, Campos EA, Syrjanen KJ. Detection of high-risk human papillomavirus (HPV) DNA by Hybrid Capture II in women referred due to atypical glandular cells in the primary screening. Diagn Cytopathol 2004;31:19-22.
29. Nicolau SM, Camargo CG, Stavale JN, Castelo A, Dores GB, Lorincz A, de Lima GR. Human papillomavirus DNA detection in male sexual partners of women with genital human papillomavirus infection. Urology 2005;65:251-5.
30. Syrjanen K, Naud P, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Matos J, Gontijo R, Sarian L, et al. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. Anticancer Res 2005;25:3469-80.
31. Holanda F, Jr, Castelo A, Veras TM, de Almeida FM, Lins MZ, Dores GB. Primary screening for cervical cancer through self sampling. Int J Gynaecol Obstet 2006;95:179-84.
32. Miranda Pereira SM, Castelo A, Makabe S, Utagawa ML, Di Loreto C, Sakamoto Maeda MY, Marques JA, Santoro CL, Filho AL, Das Dores GB. Screening for cervical cancer in high-risk populations: DNA pap test or Hybrid Capture II test alone? Int J Gynecol Pathol 2006;25:38-41.
33. Taha NS, Focchi J, Ribalta JC, Castelo A, Lorincz A, Dores GB. Universal collection medium (UCM) is as suitable as the standard transport medium (STM) for Hybrid Capture II (HC-2) assay. J Clin Virol 2006;36:32-5.
34. Mendoza JA, Munoz M, Vielma S, Noguera ME, Lopez M, Toro M. Infeccion cervical por el virus del papiloma humano: diagnostico por citologia y por captura de hibridos del ADN viral. Rev. Obstet Ginecol Venez 2000;60:103-7.
35. Flores Y, Shah K, Lazcano E, Hernandez M, Bishai D, Ferris DG, Lorincz A, Hernandez P, Salmeron J. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: the Morelos HPV Study. Salud Publica Mex 2002;44:335-44.
36. Salmeron J, Lazcano-Ponce E, Lorincz A, Hernandez M, Hernandez P, Leyva A, Uribe M, Manzanares H, Antunez A, Carmona E, Ronnett BM, Sherman ME, et al. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 2003;14:505-12.
37. Ramachandran S, Bell L, Lundy T, Nazarenko N, Eder P, Lorincz A. Alternative technologies for cost-effective HPV screening in developing countries. Abstract PO21-06, Eurogin, 6th International Multidisciplinary Congress, Paris, France, 2006.141.